Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Cited by (1,049)

Items 601–700 of 1,049

1. Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors
   Nicholas Mitsiades, Clifford C. Sung, Nikolaus D. Schultz, Daniel Costin Danila, Bin He, Vijay Kumar Eedunuri, Martin Fleisher, Chris Sander, Charles L. Sawyers, Howard I. Scher · 2012 · Cancer Research
2. Various Aspects of a Gene Editing System—CRISPR–Cas9
   Edyta Janik, Marcin Niemcewicz, Michał Ceremuga, Łukasz Krzowski, Joanna Saluk, Michał Bijak · 2020 · International Journal of Molecular Sciences
3. Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer
   Kaiyang Zhang, Erdoğan Pekcan Erkan, Sanaz Jamalzadeh, Jun Dai, Noora Andersson, Katja Kaipio, Tarja Lamminen, Naziha Mansuri, Kaisa Huhtinen, Olli Carpén et al. · 2022 · Science Advances
4. Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436)
   Katherine L. Nathanson, Anne‐Marie Martin, Bradley Stephen Wubbenhorst, Joel D. Greshock, Richard Letrero, Kurt P D'Andrea, Steven J O'Day, Jeffrey R. Infante, Gerald Steven Falchook, Hendrik‐Tobias Arkenau et al. · 2013 · Clinical Cancer Research
5. Comparative analysis of mathematical models of cell death and thermal damage processes
   John A. Pearce · 2013 · International Journal of Hyperthermia
6. 3D Bioprinted cancer models: Revolutionizing personalized cancer therapy
   Robin Augustine, Sumama Nuthana Kalva, Rashid Ahmad, Alap Ali Zahid, Shajia Hasan, Ajisha Nayeem, Lana McClements, Anwarul Hasan · 2021 · Translational Oncology
7. Emerging Signaling Pathways in Hepatocellular Carcinoma
   Agrin Moeini, Helena Cornellà, Augusto Villanueva · 2012 · Liver Cancer
8. Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
   Reuben, Alexandre, Spencer, Christine N., Prieto, Peter A., Gopalakrishnan, Vancheswaran, Reddy, Sangeetha M., Miller, John P., Mao, Xizeng, De Macedo, Mariana Petaccia, Chen, Jiong, Song, Xingzhi et al. · 2017 · npj Genomic Medicine
9. Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo
   Greg M. Thurber, Katy S. Yang, Thomas Reiner, Rainer H. Köhler, Peter Karl Sorger, Tim J. Mitchison, Ralph Weissleder · 2013 · Nature Communications
10. Tumor Evolution as a Therapeutic Target
    Nabil Amirouchene-Angelozzi, Charles Swanton, Alberto Bardelli · 2017 · Cancer Discovery
11. Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance
    Young‐Jun Park, Da‐Sol Kuen, Yeonseok Chung · 2018 · Experimental & Molecular Medicine
12. Cytokinesis in Animal Cells
    Pier Paolo D’Avino, Maria Grazia Giansanti, Mark P. Petronczki · 2015 · Cold Spring Harbor Perspectives in Biology
13. HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma
    Courtney, Kevin D., Ma, Yuanqing, Diaz de Leon, Alberto, Christie, Alana, Xie, Zhiqun, Woolford, Layton, Singla, Nirmish, Joyce, Allison, Hill, Haley, Madhuranthakam, Ananth J. et al. · 2020 · Clinical Cancer Research
14. A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
    Sharanya Sivanand, Samuel Peña‐Llopis, Hong Zhao, Blanka Kucejová, Patrick Spence, Andrea Pavía-Jiménez, Toshinari Yamasaki, David J. McBride, Jessica M. Gillen, Nicholas C. Wolff et al. · 2012 · Science Translational Medicine
15. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma
    Xue, Ruidong, Li, Ruoyan, Guo, Hua, Guo, Lin, Su, Zhe, Ni, Xiaohui, Qi, Lisha, Zhang, Ti, Li, Qiang, Zhang, Zemin et al. · 2016 · Gastroenterology
16. Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
    Jermaine Ian George Coward, Angus Silas Harding · 2014 · Frontiers in Oncology
17. Molecular and cellular heterogeneity: the hallmark of glioblastoma
    Diane J. Aum, David H. Kim, Thomas Beaumont, Eric C. Leuthardt, Gavin P. Dunn, Albert H. Kim · 2014 · Neurosurgical FOCUS
18. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
    Martin Pichler, George A. Călin · 2015 · British Journal of Cancer
19. The relevance of EMT in breast cancer metastasis: Correlation or causality?
    Ruben Bill, Gerhard Christofori · 2015 · FEBS Letters
20. Digital pathology and image analysis in tissue biomarker research
    Peter W. Hamilton, Peter Bankhead, Yinhai Wang, Ryan A. Hutchinson, Declan Kieran, Darragh G. McArt, Jacqueline A. James, Manuel Salto‐Tellez · 2014 · Methods
21. Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer
    Pierre‐Emmanuel Colombo, Michel Fabbro, Charles G. Theillet, Frédéric Bibeau, Philippe Rouanet, Isabelle Laure Ray-Coquard · 2013 · Critical Reviews in Oncology/Hematology
22. The Emerging Function and Mechanism of ceRNAs in Cancer
    Yunfei Wang, Jiakai Hou, Dandan He, Ming Sun, Peng Zhang, Yonghao Yu, Yiwen Chen · 2016 · Trends in Genetics
23. Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features
    Yuko Omori, Yusuke Ono, Mishie Ann Tanino, Hidenori Karasaki, Hiroshi Yamaguchi, Toru Furukawa, Katsuro Enomoto, Jun Ueda, Atsuko Sumi, Jin Katayama et al. · 2018 · Gastroenterology
24. Clinical application and detection techniques of liquid biopsy in gastric cancer
    Shuo Ma, Meiling Zhou, Yanhua Xu, Xinliang Gu, Mingyuan Zou, Gulinaizhaer Abudushalamu, Yuming Yao, Xiaobo Fan, Guoqiu Wu · 2023 · Molecular Cancer
25. Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
    Toni K. Choueiri, Thomas B. Powles, Katriina Johanna Peltola, Guillermo de Velasco, Mauricio Burotto, Cristina Suárez, Pooja Ghatalia, Roberto Iacovelli, Elaine T. Lam, Elena Verzoni et al. · 2024 · New England Journal of Medicine
26. An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
    Jonas, Oliver, Landry, Heather M., Fuller, Jason E., Santini, John T., Baselga, Jose, Tepper, Robert I., Cima, Michael J., Langer, Robert · 2015 · Science Translational Medicine
27. Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects
    Jeremy M. Simon, Kathryn E. Hacker, Darshan Singh, A. Rose Brannon, Joel S. Parker, Matthew Weiser, Thai H. Ho, Pei-Fen Kuan, Eric Jonasch, Terrence S. Furey et al. · 2013 · Genome Research
28. Rhamnetin and Cirsiliol Induce Radiosensitization and Inhibition of Epithelial-Mesenchymal Transition (EMT) by miR-34a-mediated Suppression of Notch-1 Expression in Non-small Cell Lung Cancer Cell Lines
    Ji‐Hoon Kang, EunGi Kim, Wanyeon Kim, Ki Moon Seong, HyeSook Youn, Jung Woo Kim, Joon Kim, BuHyun Youn · 2013 · Journal of Biological Chemistry
29. Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non–Small Cell Lung Cancer: A Meta-analysis
    Mantang Qiu, Jie Wang, Youtao Xu, Xiangxiang Ding, Ming Li, Feng Jiang, Lin Xu, Rong H. Yin · 2014 · Cancer Epidemiology Biomarkers & Prevention
30. Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed
    Wendie D. den Brok, Caroline H. Speers, Lovedeep Gondara, Emily Baxter, Scott K. Tyldesley, Caroline A. Lohrisch · 2016 · Breast Cancer Research and Treatment
31. Transmissible Dog Cancer Genome Reveals the Origin and History of an Ancient Cell Lineage
    Elizabeth P. Murchison, David C. Wedge, Ludmil B. Alexandrov, Beiyuan Fu, Iñigo Martincorena, Zemin Ning, José M. C. Tubío, Emma Werner, Jan Allen, Andrígo Barboza De Nardi et al. · 2014 · Science
32. Tumor evolution and chemoresistance in ovarian cancer
    Soochi Kim, Youngjin Han, Se Ik Kim, Hee‐Seung Kim, Seong Jin Kim, Yong Sang Song · 2018 · npj Precision Oncology
33. Digital image analysis outperforms manual biomarker assessment in breast cancer
    Gustav Stålhammar, Nelson Fuentes Martínez, Michael Friis Lippert, Nicholas P. Tobin, Ida Mølholm, Lorand Levente Kis, Gustaf Rosin, Mattias Rantalainen, Lars Pedersen, Jonas C. S. Bergh et al. · 2016 · Modern Pathology
34. Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration
    Jean‐Sébastien Frenel, Suzanne Carreira, JANE C. GOODALL, Desam Roda, Raquel Pérez-López, Nina Tunariu, Ruth Riisnaes, Susana Miranda, Ines Figueiredo, Daniel Nava Rodrigues et al. · 2015 · Clinical Cancer Research
35. Expanding the computational toolbox for mining cancer genomes
    Li Ding, Michael C. Wendl, Joshua F. McMichael, Benjamin J. Raphael · 2014 · Nature Reviews Genetics
36. Evolution and dynamics of pancreatic cancer progression
    Shinichi Yachida, Christine A. Iacobuzio–Donahue · 2013 · Oncogene
37. Targeted, High-Depth, Next-Generation Sequencing of Cancer Genes in Formalin-Fixed, Paraffin-Embedded and Fine-Needle Aspiration Tumor Specimens
    Andrew G. Hadd, Jeff Houghton, Ashish Kumar Choudhary, Sachin Sah, Liangjing Chen, Adam C. Marko, Tiffany Sanford, Kalyan Buddavarapu, Julie Krosting, Lana Xia Garmire et al. · 2013 · Journal of Molecular Diagnostics
38. Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors
    Mohid Shakil Khan, Amy A. Kirkwood, Theodora Tsigani, Jorge García-Hernández, John Anthony Hartley, Martyn Evan Caplin, Tim Meyer · 2012 · Journal of Clinical Oncology
39. Circulating tumor cells: from new biological insights to clinical practice
    Xuyu Gu, Shiyou Wei, Xin Lv · 2024 · Signal Transduction and Targeted Therapy
40. Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis
    Catherine Choy Smith, Amy L. Paguirigan, Grace R. Jeschke, Kimberly C. Lin, Evan Massi, Theodore C. Tarver, Chen-Shan Chin, Saurabh Asthana, Adam B. Olshen, Kevin J. Travers et al. · 2017 · Blood
41. Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies
    Wenxuan Du, Olivier Elemento · 2014 · Oncogene
42. Molecular heterogeneity in breast cancer: State of the science and implications for patient care
    Rachel E. Ellsworth, Heather L. Blackburn, Craig D. Shriver, Patrick Soon‐Shiong, Darrell L. Ellsworth · 2016 · Seminars in Cell and Developmental Biology
43. Data-driven identification of prognostic tumor subpopulations using spatially mapped t-SNE of mass spectrometry imaging data
    Walid M. Abdelmoula, Benjamin Balluff, Sonja Englert, Jouke Dijkstra, Marcel J. T. Reinders, Axel Karl Walch, Liam Andrew McDonnell, Boudewijn P. F. Lelieveldt · 2016 · Proceedings of the National Academy of Sciences
44. Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer
    Sina Halvaei, Shiva Daryani, Zahra Eslami‐S, Tannaz Samadi, Narges Jafarbeik Iravani, Tayebeh Oghabi Bakhshaiesh, Keivan Majidzadeh‐A, Rezvan Esmaeili · 2017 · Molecular Therapy — Nucleic Acids
45. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
    Carolyn S. Grove, George S. Vassiliou · 2014 · Disease Models & Mechanisms
46. Chromosome 3p Loss–Orchestrated VHL, HIF, and Epigenetic Deregulation in Clear Cell Renal Cell Carcinoma
    James J.-D. Hsieh, Valerie H. Le, Toshinao Oyama, Christopher J. Ricketts, Thai H. Ho, Emily H. Y. Cheng · 2018 · Journal of Clinical Oncology
47. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study
    Alejandro Sánchez, Helena F. Furberg, Fengshen Kuo, Lynda H. Vuong, Yasser M. A. Ged, Sujata Patil, Irina Ostrovnaya, Stacey Petruzella, Albert Reising, Parul Patel et al. · 2019 · The Lancet Oncology
48. Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
    Chin, Re-I, Chen, Kevin, Usmani, Abul, Chua, Chanelle, Harris, Peter K., Binkley, Michael S., Azad, Tej D., Dudley, Jonathan C., Chaudhuri, Aadel A. · 2019 · Molecular Diagnosis & Therapy
49. SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
    Nnennaya Kanu, Eva Camilla Gronroos, Pierre Martinez, Rebecca A. Burrell, Xin Yi Goh, Jiřina Bártková, Apolinar Maya‐Mendoza, Martin Mistrík, Andrew Rowan, Harshil Patel et al. · 2015 · Oncogene
50. Advances in kinase targeting: current clinical use and clinical trials
    Mathias Rask‐Andersen, Jin Zhang, Doriano Fabbro, Helgi B. Schiöth · 2014 · Trends in Pharmacological Sciences
51. Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium
    Kenneth Aldape, Samirkumar B. Amin, David M. Ashley, Jill S. Barnholtz‐Sloan, Amanda J Bates, Rameen Beroukhim, Christoph Bock, Daniel Jay Brat, Elizabeth B. Claus, J Costello et al. · 2018 · Neuro-Oncology
52. Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
    Jianpeng Gao, Wei Xu, Wentao Liu, Min Yan, Zhenggang Zhu · 2018 · World Journal of Gastroenterology
53. Metabolomics technology and bioinformatics for precision medicine
    Rajeev K. Azad, Vladimir Shulaev · 2017 · Briefings in Bioinformatics
54. Emerging targeted agents in metastatic breast cancer
    Dimitrios Zardavas, Jose M Baselga, Martine J Piccart · 2013 · Nature Reviews Clinical Oncology
55. Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)
    Chris Karlovich, Jonathan Wade Goldman, Jong‐Mu Sun, Elaina Mann, Lecia Van Dam Sequist, Krzysztof Konopa, Wei Wen, Philipp Angenendt, Leora Horn, David Robert Spigel et al. · 2016 · Clinical Cancer Research
56. Genomic Approaches to Understanding Response and Resistance to Immunotherapy
    David A. Braun, Kelly P. Burke, Eliezer M. Van Allen · 2016 · Clinical Cancer Research
57. Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
    Maria Vinci, Anna Burford, Valeria Molinari, Ketty Kessler, Sergey Popov, Matthew Clarke, Kathryn R. Taylor, Helen N. Pemberton, Christopher J. Lord, Alice Gutteridge et al. · 2018 · Nature Medicine
58. PHGDH defines a metabolic subtype in lung adenocarcinomas with poor prognosis
    Zhang, Boxi, Zheng, Adi, Hydbring, Per, Ambroise, Gorbatchev, Ouchida, Amanda Tomie, Goiny, Michel, Vakifahmetoglu-Norberg, Helin, Norberg, Erik · 2017 · Cell Reports
59. ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
    David T. W. Chu, Costanza Paoletti, Christina L. Gersch, Dustin A. VanDenBerg, Daniel J. Zabransky, Rory L. Cochran, Hong Yuen Wong, Patricia Valda Toro, Justin R. Cidado, Sarah Croessmann et al. · 2015 · Clinical Cancer Research
60. Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
    Roberto Iacovelli, Franco Nolè, Elena Verri, Giuseppe Renne, Chiara Paglino, Matteo Santoni, Maria Cossu Rocca, Palma Giglione, Gaetano Aurilio, Daniela Cullurà et al. · 2015 · Targeted Oncology
61. Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
    David N. Brown, Dominiek Smeets, Borbála Székely, Denis Larsimont, Attila Marcell Szász, Pierre-Yves Adnet, Françoise Rothé, Ghizlane Rouas, Zsófia Nagy, Zsófia Faragó et al. · 2017 · Nature Communications
62. Progress of exosomes in the diagnosis and treatment of lung cancer
    Kanghong Xu, Chengpeng Zhang, Tiantian Du, Abakundana Nsenga Ariston Gabriel, Xue Wang, Xiaomeng Li, Li Jun Sun, Nan Wang, Xinquan Jiang, Yi Zhang · 2020 · Biomedicine & Pharmacotherapy
63. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
    Zilong Zhou, Lele Cong, Xianling Cong · 2021 · Frontiers in Oncology
64. Advances in patient-derived tumor xenografts: From target identification to predicting clinical response rates in oncology
    Edward C. Rosfjord, Judy Lucas, Gang Li, Hans‐Peter Gerber · 2014 · Biochemical Pharmacology
65. A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives
    Russo, Alessandro, Franchina, Tindara, Rita Ricciardi, Giuseppina Rosaria, Picone, Antonio, Ferraro, Giuseppa, Zanghì, Mariangela, Toscano, Giuseppe, Giordano, Antonio, Adamo, Vincenzo · 2015 · Oncotarget
66. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer
    Vignot, Stéphane, Frampton, Garrett M., Soria, Jean-Charles, Yelensky, Roman, Commo, Frédéric, Brambilla, Christian, Palmer, Gary, Moro-Sibilot, Denis, Ross, Jeffrey S., Cronin, Maureen T. et al. · 2013 · Journal of Clinical Oncology
67. Pragmatic issues in biomarker evaluation for targeted therapies in cancer
    Armand D.E. Gramont, Sarah Watson, Lee M. Ellis, Jordi Ahnert Rodon, Josep M. Tabernero, Aimery de Gramont, Stanley R. Hamilton · 2014 · Nature Reviews Clinical Oncology
68. Noninvasive Saliva-based EGFR Gene Mutation Detection in Patients with Lung Cancer
    Fang Wei, Chien‐Chung Lin, Aron Y. Joon, Ziding Feng, Gabriel E. Troche, Maruja E. Lira, David Chia, Mao Mao, Chung‐Liang Ho, Wu‐Chou Su et al. · 2014 · American Journal of Respiratory and Critical Care Medicine
69. Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade
    Yifeng Gu, Shannon Cohn, Alana L. Christie, Tiffani McKenzie, Nicholas C. Wolff, Quyen N. Do, Ananth J. Madhuranthakam, Iván Pedrosa, Tao Wang, Anwesha Dey et al. · 2017 · Cancer Discovery
70. The role of neoantigens in response to immune checkpoint blockade
    Nadeem Riaz, Luc G.T. Morris, Jonathan J. Havel, Vladimir Makarov, Alexis Desrichard, Timothy An-thy Chan · 2016 · International Immunology
71. From human genome to cancer genome: The first decade
    David A. Wheeler, Linghua Wang · 2013 · Genome Research
72. Leading malignant cells initiate collective epithelial cell invasion in a three-dimensional heterotypic tumor spheroid model
    Carey, Shawn P., Starchenko, Alina, McGregor, Alexandra L., Reinhart-King, Cynthia A. · 2013 · Clinical & Experimental Metastasis
73. Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
    Jose Antonio Karam, Catherine E. Devine, Diana L. Urbauer, Marisa Lozano, Tapati Maity, Kamran Ahrar, Pheroze Tamboli, Nizar M. Tannir, Christopher G. Wood · 2014 · European Urology
74. Circulating tumour cells and cell-free DNA as tools for managing breast cancer
    Leticia De Mattos‐Arruda, Javier Cortés, Libero Santarpia, Ana P. Vivancos, Josep M. Tabernero, Jorge Sergio Reis-Filho, Joan Seoane · 2013 · Nature Reviews Clinical Oncology
75. Epigenetics of lung cancer
    Scott M. Langevin, Robert Arthur Kratzke, Karl T. Kelsey · 2014 · Translational research
76. Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device
    Khoo, Bee Luan, Grenci, Gianluca, Lim, Ying Bena, Lee, Soo Chin, Han, Jongyoon, Lim, Chwee Teck · 2018 · Nature Protocols
77. Developmental pathways in colon cancer
    Fred E. Bertrand, C. William Angus, William J. Partis, George Sigounas · 2012 · Cell Cycle
78. Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing
    Mei-Chong Wendy Lee, Fernando J. López-Díaz, Shahid Y. Khan, Muhammad Tariq, Yelena Dayn, Charles Joseph Vaske, Amie Radenbaugh, Hyunsung John Kim, Beverly M. Emerson, Nader Pourmand · 2014 · Proceedings of the National Academy of Sciences
79. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
    Xin Hu, Junya Fujimoto, Lisha Ying, Junya Fukuoka, Kazuto Ashizawa, Wenyong Sun, Alexandre Reuben, Chi-Wan B. Chow, Nicholas McGranahan, Runzhe Chen et al. · 2019 · Nature Communications
80. ecancermedicalscience
    Pan Pantziarka, Gauthier Bouche, Lydie Meheus, Vidula V. Sukhatme, Vikas P. Sukhatme, Praveen Vikas · 2016 · ecancermedicalscience
81. A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer
    Frederick Hugh Wilson, Cory M. Johannessen, Federica Piccioni, Pablo Tamayo, Jong Wook Kim, Eliezer M. Van Allen, Steven M. Corsello, Marzia Capelletti, Antonio Calles, Mohit Butaney et al. · 2015 · Cancer Cell
82. Detecting repeated cancer evolution from multi-region tumor sequencing data
    Giulio Caravagna, Ylenia Giarratano, Daniele Ramazzotti, Ian P.M. Tomlinson, Trevor A. Graham, Guido Sanguinetti, Andrea Sottoriva · 2018 · Nature Methods
83. An integrative ENCODE resource for cancer genomics
    Zhang, Jing, Lee, Donghoon, Dhiman, Vineet, Jiang, Peng, Xu, Jie, McGillivray, Patrick, Yang, Hongbo, Liu, Jason, Meyerson, William, Clarke, Declan et al. · 2020 · Nature Communications
84. Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges
    Li‐Chun Lu, Chih‐Hung Hsu, Chiun Hsu, Ann‐Lii Cheng · 2016 · Liver Cancer
85. Single-cell sequencing data reveal widespread recurrence and loss of mutational hits in the life histories of tumors
    Jack Kuipers, Katharina Jahn, Benjamin J. Raphael, Niko Beerenwinkel · 2017 · Genome Research
86. Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations
    Noura J. Choudhury, Alexa Campanile, Tatjana Antic, Kai Lee Yap, Carrie A. Fitzpatrick, James Lloyd Wade, Theodore Karrison, Walter Michael Stadler, Yusuke Nakamura, Peter H. O’Donnell · 2016 · Journal of Clinical Oncology
87. Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology
    Nicole M. Kuderer, Kimberly A. Burton, Sibel H. Blau, Andrea L. Rose, Stephanie Parker, Gary H. Lyman, C. Anthony Blau · 2016 · JAMA Oncology
88. Reconstructing metastatic seeding patterns of human cancers
    Johannes G. Reiter, Alvin P. Makohon-Moore, Jeffrey M. Gerold, Ivana Božić, Krishnendu Chatterjee, Christine A. Iacobuzio–Donahue, Bert Vogelstein, Martin A. Nowak · 2017 · Nature Communications
89. Targeting minimal residual disease: a path to cure?
    Marlise Rachael Luskin, Mark Alan Murakami, Scott R. Manalis, David M. Weinstock · 2018 · Nature reviews. Cancer
90. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway
    Leila Hamzehzadeh, Stephen Lawrence Atkin, Muhammed A. Majeed, Alexandra E. Butler, Amirhossein Sahebkar · 2018 · Journal of Cellular Physiology
91. Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors
    David Eric Piccioni, Achal Singh Achrol, Lesli Ann Kiedrowski, Kimberly C. Banks, Najee Boucher, Garni Barkhoudarian, Daniel F. Kelly, Tiffany Juarez, Richard Burnham Lanman, Victoria M. Raymond et al. · 2019 · CNS Oncology
92. Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
    Sakshi Gulati, Pierre Martinez, Tejal Joshi, Nicolai J. Birkbak, Cláudio R. Santos, Andrew Rowan, Lisa M. Pickering, Martin Eric Gore, James Larkin, Zoltán Szállási et al. · 2014 · European Urology
93. High-Definition Reconstruction of Clonal Composition in Cancer
    Andrej Fischer, Ignacio Vázquez-Garćıa, Christopher J. R. Illingworth, Ville Mustonen · 2014 · Cell Reports
94. BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance
    Gerald Steven Falchook, Jonathan C. Trent, Michael Charles Heinrich, Carol Beadling, J. Patterson, Christel C. Bastida, S Blackman, Razelle Kurzrock · 2013 · Oncotarget
95. Genomic profiling in renal cell carcinoma
    Nazlı Dizman, Errol James Philip, Sumanta Kumar Pal · 2020 · Nature Reviews Nephrology
96. Challenges in the management of advanced, ER-positive, HER2-negative breast cancer
    Christopher David Hart, Ilenia Migliaccio, Luca Malorni, Cristina Guarducci, Laura Biganzoli, Angelo Di Leo · 2015 · Nature Reviews Clinical Oncology
97. Chromosomal Instability as a Driver of Tumor Heterogeneity and Evolution
    Samuel F. W. Bakhoum, Dan Avi Landau · 2017 · Cold Spring Harbor Perspectives in Medicine
98. The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials
    written on behalf of AME Lung Cancer Collaborative Group, Yangyang Xu, Bing Wan, Xi Chen, Ping Zhan, Yuan Zhao, Tianli Zhang, Hongbing Liu, Muhammad Zubair Afzal, Said Dermime et al. · 2019 · Translational Lung Cancer Research
99. Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985)
    Zhuyu Xu, Dandan Guo, Zhongliang Jiang, Rongsheng Tong, Peidu Jiang, Lan Bai, Lu Chen, Yuxuan Zhu, Chun Hua Guo, Jianyou Shi et al. · 2019 · European Journal of Medicinal Chemistry
100. Phylogenetic Quantification of Intra-tumour Heterogeneity
     Roland F. Schwarz, Anne C. Trinh, Botond Sipos, James D. Brenton, Nick Goldman, Florian M. Markowetz · 2014 · PLoS Computational Biology